Interactions of γ-hydroxy butyrate with ethanol and NCS 382
-
Add time:07/26/2019 Source:sciencedirect.com
We examined the effects of γ-hydroxy butyrate (GHB) alone and in combination with either ethanol or NCS 382 [(2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene], a purported antagonist at the GHB receptor. These effects were examined on the responding of rats under a fixed-ratio (FR) 10 schedule of sugar solution (14%, w/v; 0.1 ml) presentation. GHB dose-relatedly decreased responding. When GHB was combined with ethanol, the effects of the two drugs were less than additive. NCS 382 did not antagonize the rate-decreasing effects of GHB. These observations are consistent with the notion that many of the behavioral actions of exogenously administered GHB result from GHB's actions at sites other than the GHB receptor, and are inconsistent with the popular notion that the effects of GHB and ethanol are synergistic.
We also recommend Trading Suppliers and Manufacturers of NCS-382 (cas 131733-92-1). Pls Click Website Link as below: cas 131733-92-1 suppliers
Prev:Regional Fos-expression induced by γ-hydroxybutyrate (GHB): Comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382 (cas 131733-92-1)
Next:Competitive inhibition of lipolytic enzymes. IX. A comparative study on the inhibition of pancreatic phospholipases A2 from different sources by (R)-2-acylamino phospholipid analogues) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Regional Fos-expression induced by γ-hydroxybutyrate (GHB): Comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382 (cas 131733-92-1)07/25/2019
- Stereoselectivity of NCS-382 (cas 131733-92-1) binding to γ-hydroxybutyrate receptor in the rat brain07/24/2019
- In vitro toxicological evaluation of NCS-382 (cas 131733-92-1), a high-affinity antagonist of γ-hydroxybutyrate (GHB) binding07/23/2019
- Toxicologic/transport properties of NCS-382 (cas 131733-92-1), a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder07/22/2019


